Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial

NCT07103980 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Post-Infectious Cough

Interventions

DRUG: Mesenchymal stem cell derived exosome nebulization combined with compound methoxyphenamine capsule
DRUG: Normal saline nebulization combined with the compound methoxyphenamine capsule

Sponsor

Shanghai Changzheng Hospital